L98.3 Eosinophilic cellulitis [Wells]

Name of the Condition

• Eosinophilic cellulitis [Wells]

Summary

Eosinophilic cellulitis, also known as Wells syndrome, is a rare inflammatory skin condition characterized by recurrent episodes of erythematous, edematous plaques or nodules. The condition is marked by a dense infiltrate of eosinophils in the skin and may be associated with underlying systemic diseases or triggers. Lesions typically resolve spontaneously but can recur, and the diagnosis relies on clinical presentation and histopathologic findings.

Causes

The exact cause of eosinophilic cellulitis is not fully understood. It may be triggered by insect bites, drug reactions, infections, or underlying hematologic or autoimmune disorders. Some cases occur without a clear precipitating factor, suggesting potential immune dysregulation or hypersensitivity mechanisms.

Risk Factors

Risk factors are not well defined due to the rarity of the condition. Associations have been reported with atopy, asthma, parasitic infections, or exposure to certain medications (e.g., antibiotics, nonsteroidal anti-inflammatory drugs). Underlying hematologic malignancies or autoimmune diseases may also increase susceptibility.

Symptoms

Symptoms include sudden onset of painful or pruritic erythematous plaques or nodules, often with a "flame" or "swirled" appearance. Lesions may progress to bullae or vesicles and typically resolve over weeks, leaving residual hyperpigmentation. Systemic symptoms like fever or malaise are uncommon but may occur in severe cases.

Diagnosis

Diagnosis is based on clinical presentation and histopathologic examination. A skin biopsy reveals a dense eosinophilic infiltrate in the dermis, often with flame figures (clusters of eosinophils and collagen). Laboratory tests may show peripheral eosinophilia, and imaging or additional workup may be performed to rule out underlying causes.

Treatment Options

Treatment is tailored to severity and may include topical or systemic corticosteroids for acute flares. Antihistamines can help manage pruritus. In refractory cases, other immunosuppressants (e.g., dapsone, cyclosporine) or targeted therapies may be considered. Addressing underlying triggers or comorbidities is essential for long-term management.

Prognosis and Follow-Up

Prognosis is generally good, with lesions resolving spontaneously over weeks to months. Recurrences are common, and long-term follow-up may be needed to monitor for relapses or associated conditions. Most patients experience no permanent skin damage, though scarring or hyperpigmentation can occur.

Complications

Complications are rare but may include secondary infection, persistent hyperpigmentation, or scarring. In cases linked to underlying malignancies or severe systemic disease, outcomes depend on the associated condition. Chronic or recurrent disease may impact quality of life due to discomfort or cosmetic concerns.

Lifestyle & Prevention

Avoid known triggers (e.g., specific medications, insect bites) when possible. Maintain good skin hygiene and promptly treat infections. For patients with atopy or asthma, managing these conditions may reduce flare risk. Sun protection and gentle skin care are recommended to minimize irritation.

When to Seek Professional Help

Seek care if lesions are severe, spreading, or accompanied by fever, pain, or systemic symptoms. Prompt evaluation is advised for new or worsening lesions, especially if they do not resolve or recur frequently. Underlying causes (e.g., infections, malignancies) require timely diagnosis and management.

Tips for Medical Coders

Code L98.3 is assigned for eosinophilic cellulitis (Wells syndrome). Documentation should specify the clinical presentation, histopathologic findings (if available), and any associated triggers or comorbidities. Ensure the diagnosis is clearly differentiated from other eosinophilic or inflammatory skin conditions to support accurate coding.